Brief: MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position
13/05/2025 21:26
May 13 (Reuters) - MEI Pharma Inc MEIP.O: MEI PHARMA REPORTS THIRD QUARTER FISCAL YEAR 2025 CASH POSITION MEI PHARMA INC: EVALUATION OF STRATEGIC ALTERNATIVES IS ONGOING Source text: ID:nBw4PgQNFa Further company coverage: MEIP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations